Mark W Leonard

Title: Innovations of Mark W Leonard

Introduction

Mark W Leonard is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of biomedical engineering, particularly in the development of chimeric antigen receptors (CARs) for cancer treatment. With a total of 3 patents, his work has the potential to impact therapeutic strategies for patients.

Latest Patents

One of his latest patents is titled "Method of treatment using anti-CD19 rituximab-resistant chimeric antigen receptors." This patent provides polynucleotides encoding CARs that specifically bind to CD19 and are resistant to rituximab binding. It also includes immune cells that comprise these CD19-specific CARs, such as CAR-T cells. Another significant patent is "Formulations and processes for CAR T cell drug products." This patent outlines formulations and drug product processes that enhance cell viability and minimize waste during the manufacturing of formulated cells for drug products.

Career Highlights

Mark W Leonard is currently associated with Allogene Therapeutics, Inc., where he continues to innovate in the field of immunotherapy. His work focuses on improving the efficacy and safety of CAR-T cell therapies, which are crucial in the fight against various cancers.

Collaborations

He collaborates with esteemed colleagues such as Thomas Charles Pertel and Barbra Johnson Sasu, contributing to a dynamic research environment that fosters innovation and development in cancer therapies.

Conclusion

Mark W Leonard's contributions to the field of biomedical engineering and his innovative patents are paving the way for advancements in cancer treatment. His work exemplifies the impact of dedicated inventors in the medical field.